Friday, 30 August
| 16.00-17.00 | Pre-symposium I, Otsuka (chair Kaj Metsärinne, Turku, FIN) Introduction by Viktoria Sjöblom Management of ADPKD 2019; learning and practical perspectives from Cologne Thomas Benzing |
| 17.00-18.00 | Pre-symposium II, Astellas, (chair Kaj Metsärinne, FIN) Kidney transplantation seen from a patient perspective – the responsibility for a successful outcome Sari Högström, Executive Director, The Finnish Kidney and Liver Association & Vilma Niemi, Patient Representative, The Finnish Kidney and Liver Association |
| 18.00-18.20 | Coffee break |
| 18.20-19.00 | Candle light lecture: Is the progression of DKD preventable? Prof. Dick de Zeeuw, Groningen, NL |
| 19.30- | Get-together party |
Saturday, 31 August
| 8.00-9.00 | Industry symposium 1, Nordic Medcom ”End Stage Renal Disease Challenges with Volume Overload, Heart Failure and Hypertension” Survival After End Stage Renal Failure: Preventing Cardiac Death in ESRD Patients – Allan Collins More Frequent Therapy in Europe: The Key to Volume and Symptom Control? – Mari Vilpakka A Patient Experience on Fluid Management and Blood Pressure Control – Johan Sandström |
| 9.00-10.30 | Session 1 – Transplantation (chair: Kaj Metsärinne, Turku, FIN & Mai Rosenberg, EST) |
| Optimizing the living donor pool – experiences from a successful exchange program J. van de Wetering, Rotterdam, NL Risks for the living donor Geir Mjoen, Oslo, NO Current risks and benefits for the kidney transplant recipient Ilkka Helanterä, Helsinki, FIN |
|
| 10.30-11.00 | Coffee & exhibition |
| 11.00-12.30 | Session 2 – Hypertension (chair: Ilkka Pörsti, Tampere, FIN) |
| Atherosclerotic renovascular disease Niina Koivuviita, Turku, FIN Fibromuscular dysplasia: from an uncommon cause of renovascular hypertension to a less rare systemic arterial disease Alexandre Persu, Brussels, BEL |
|
| 12.30-13.30 | Lunch and exhibition |
| 13.30-15.00 | Session 3 – Diabetes and kidney disease (chair Per-Henrik Groop, FIN & Marius Miglinas, Vilnius, LTU) |
| New classification of diabetes – implications for DKD? Leif Groop, FIN & SWE Functional MRI – the new kidney biopsy? Aghogho Odudu, Manchester, UK Diabetic complications in individuals living with type 1 diabetes for more than 50 years D. Pongrac-Barlovic Ljubljana, SLO |
|
| 15.00-15.30 | Coffee and exhibition |
| 15.30-16.30 | Session 4 – Genetics and pathophysiology of renal diseases (chair: Hannu Jalanko, Helsinki, FIN) |
| Complement system in kidney disease Seppo Meri, Helsinki, FIN Podocyte genetics and pathology in CKD Jaakko Patrakka, Stockholm, SWE |
|
| 16.30-17.30 | Industry symposium 2, Vifor Pharma Nordiska Ab Hyperkalemia and iron deficiency in the cardiorenal patient – what should treatment aim for? What are the treatment options that allows for management of the comorbid CKD patient and what challenges are involved? Satu Mäkelä, Tampere University Hospital, FIN Knut Aasarød, St Olav University Hospital, NOR Marie Evans, Karolinska Institutet, SWE |
| 18.00- | Jogging by the river Aura with colleagues from Turku Congress dinner |
Sunday, 1 September
| 8.00-9.00 | Industry symposium 3, Baxter Oy |
| 9.00-10.30 | Session 5 – Homedialysis (chair Eero Honkanen, Helsinki, FIN) |
| Critical analysis of Quality of life in different dialysis modalities Patrik Finne, Helsinki, FIN Health economic perspectives on home dialysis Helena Rydell, Stockholm, SWE Role of home dialysis in dialysis strategy planning Marianne Rix, Copenhagen, DEN |
|
| 10.30-11.00 | Coffee & exhibition |
| 11.00-12.30 | Session 6 – State-of-the-art (chair Mikko Haapio, Helsinki, FIN) |
| Treatment of IgA nephropathy Thomas Rauen, Aachen, GER RRT for AKI Claudio Ronco, Vicenza, ITA |
|
| 12.30-13.40 | Lunch and exhibition |
| 13.40-15.00 | Session 7 – eHealth (chair Satu Mäkelä, Tampere, FIN) |
| Digitalization and the change in healthcare Visa Honkanen, Helsinki, FIN Digital innovations in nephrology Virpi Rauta, Helsinki, FIN |
|
| 15.00-15.30 | Coffee and exhibition |
| 15.30-17.00 | Session 8 – Best posters (Chair Aivars Pētersons, LVA) |
| Exploring histological and clinical predictors of 1-year ESRD risk in ANCA-GN presenting with eGFR≤15ml/min/1,73m2 Lars Bostad, Bergen, NOR Primary renal disease and effect of comorbidities on survival of patients on renal replacement therapy Patrik Finne, Helsinki, FIN Fractures and their sequelae in non-dialysis dependent chronic kidney disease; the Stockholm CREAtinine Measurements (SCREAM) project Björn Runesson, Stockholm, SWE Prevalence of low bone volume and fractures after kidney transplantation Satu Keronen, Helsinki, FIN |
|
| 17.00-18.00 | Industry symposium 4, Sanofi |
| 19.30- | Congress dinner |
Monday, 2 September
| 9.00-10.00 | Industry symposium 4, Medans Oy |
| 10.00-11.30 | Session 9 – Geriatric nephrology (Chair: Heikki Saha, Tampere, FIN) |
| Shared decision making and the option of conservative treatment James Heaf, Copenhagen, DEN Transplantation in the elderly Kristian Heldal, Oslo, NOR Palliative treatment of ESRD patients Edwina Brown, London, UK |
|
| 11.30-12.00 | Coffee and exhibition |
| 12.00-13.30 | Session 10 – State of the Art lectures (chairs: Kaj Metsärinne, Turku, FIN & Helle Thiesson, DEN) |
| Vasculitis 2019 Mårten Segelmark, Lund, SWE The gut-kidney axis Peter Rossing, Copenhagen, DEN Treatment of Membranous glomerulonephritis Eero Honkanen, Helsinki, FIN |
|
| 13.30- | Farewell |
Changes to programme are possible.
Preliminary Session Topics
- eHealth
- Geriatric nephrology
- Homedialysis
- Transplantation
- Diabetes and kidney disease
- Hypertension
- Coagulation defects in kidney disease
- Pediatric nephrology
- Best posters
- State of the art lectures
- Acute kidney injury